Low Cylinder Toric

Phase 4CompletedNCT00732030

Alcon Research26 enrolled

Overview

Study evaluates the visual outcomes and patient satisfaction after implantation of a toric intraocular lens (IOL).

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Cataracts

Interventions

Toric IOL (SN60T3)DEVICE

Each enrolled eye implanted with the AcrySof Toric Model SN60T3 intraocular lens (IOL) for the treatment of cataract.

Eligibility

Sex: ALLMin age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosed with Cataracts * Predicted residual corneal astigmatism between 0.75 and 1.03 Diopters (D) Exclusion Criteria: * Preoperative ocular pathology * Planned monovision

Locations (1)

Alcon Call Center for Trial Locations

Fort Worth, Texas, United States

Outcomes

Primary Outcomes

Uncorrected Distance Visual Acuity

Uncorrected Distance Visual Acuity at month 6 measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution". It is a unit of measure for visual acuity (VA).

Time frame: 6 months

Best Corrected Distance Visual Acuity

Best Corrected Distance Visual Acuity at month 6 measured in LogMAR. LogMAR is the "logarithm of the minimum angle of resolution". It is a unit of measure for visual acuity (VA).

Time frame: 6 Months

Residual Refractive Cylinder

Residual Refractive Cylinder at month 6 measured in diopters (D).

Time frame: 6 Month

Secondary Outcomes

Patient Satisfaction Survey

Satisfaction for daytime distance vision, nighttime distance vision, and indoors distance vision on a scale of 1 to 5, with 1 being very dissatisfied and 5 being very satisfied.

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.